ACADIA Pharmaceuticals
ACAD
#3673
Rank
โ‚ฌ2.71 B
Marketcap
16,32ย โ‚ฌ
Share price
-2.87%
Change (1 day)
-38.71%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): โ‚ฌ0.12 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.92 Billion. In 2023 the company made an earning of -โ‚ฌ49.28 Million, an increase over its 2022 earnings that were of -โ‚ฌ0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ0.12 B-353.28%
2023 -โ‚ฌ49.28 Million-76.09%
2022 -โ‚ฌ0.21 Billion27.41%
2021 -โ‚ฌ0.17 Billion-40.38%
2020 -โ‚ฌ0.28 Billion19.88%
2019 -โ‚ฌ0.23 Billion-3.92%
2018 -โ‚ฌ0.24 Billion-15.04%
2017 -โ‚ฌ0.28 Billion6.33%
2016 -โ‚ฌ0.27 Billion64.55%
2015 -โ‚ฌ0.16 Billion77.47%
2014 -โ‚ฌ89.28 Million143.69%
2013 -โ‚ฌ36.64 Million81.93%
2012 -โ‚ฌ20.14 Million-8.73%
2011 -โ‚ฌ22.07 Million-251.39%
2010 โ‚ฌ14.57 M-133.2%
2009 -โ‚ฌ43.9 Million-30.82%
2008 -โ‚ฌ63.45 Million6.43%
2007 -โ‚ฌ59.62 Million25.89%
2006 -โ‚ฌ47.36 Million36.99%
2005 -โ‚ฌ34.57 Million37.22%
2004 -โ‚ฌ25.2 Million19.96%
2003 -โ‚ฌ21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ36.18 Million-127.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.70 B 4,979.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.79 B 7,325.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.75 B 13,357.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ6.65 Billion-5,133.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ37.3 Million-128.26%๐Ÿ‡บ๐Ÿ‡ธ USA